(BTI) British American Tobacco - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: US1104481072
Stock:
Total Rating 61
Risk 84
Buy Signal -0.06
| Risk 5d forecast | |
|---|---|
| Volatility | 19.9% |
| Relative Tail Risk | -4.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.58 |
| Alpha | 66.95 |
| Character TTM | |
|---|---|
| Beta | 0.032 |
| Beta Downside | -0.035 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.47% |
| CAGR/Max DD | 1.32 |
EPS (Earnings per Share)
Revenue
Description: BTI British American Tobacco
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa. The company offers vapour products; heated products, which consists of a battery-powered device and a plant-based substance consumable that is heated; modern oral products, such as nicotine pouches; combustibles, including cigarette sticks and other tobacco stick products; traditional oral products, such as snus and moist snuff; and fine cut/roll-your-own tobacco products. It sells its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel Snus brands, as well as Vogue, Viceroy, Kool, Peter Stuyvesant, Craven A, and State Express 555 brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is headquartered in London, the United Kingdom.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 10.83b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 1.12 > 1.0 |
| NWC/Revenue: -3.57% < 20% (prev -5.30%; Δ 1.73% < -1%) |
| CFO/TA 0.11 > 3% & CFO 12.38b > Net Income 10.83b |
| Net Debt (31.24b) to EBITDA (20.34b): 1.54 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (2.20b) vs prev -1.17% < -2% |
| Gross Margin: 83.17% > 18% (prev 0.82%; Δ 8235 % > 0.5%) |
| Asset Turnover: 45.03% > 50% (prev 34.28%; Δ 10.74% > 0%) |
| Interest Coverage Ratio: 4.64 > 6 (EBITDA TTM 20.34b / Interest Expense TTM 3.27b) |
Altman Z'' 1.83
| A: -0.02 (Total Current Assets 12.68b - Total Current Liabilities 14.52b) / Total Assets 109.29b |
| B: 0.21 (Retained Earnings 22.93b / Total Assets 109.29b) |
| C: 0.13 (EBIT TTM 15.16b / Avg Total Assets 114.33b) |
| D: 0.35 (Book Value of Equity 21.25b / Total Liabilities 61.15b) |
| Altman-Z'' Score: 1.83 = BBB |
Beneish M -3.00
| DSRI: 0.83 (Receivables 3.80b/3.64b, Revenue 51.48b/40.92b) |
| GMI: 0.99 (GM 83.17% / 82.07%) |
| AQI: 1.02 (AQ_t 0.84 / AQ_t-1 0.83) |
| SGI: 1.26 (Revenue 51.48b / 40.92b) |
| TATA: -0.01 (NI 10.83b - CFO 12.38b) / TA 109.29b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = A |
What is the price of BTI shares?
As of February 24, 2026, the stock is trading at USD 62.10 with a total of 6,299,408 shares traded.
Over the past week, the price has changed by +5.42%, over one month by +4.97%, over three months by +14.87% and over the past year by +73.41%.
Over the past week, the price has changed by +5.42%, over one month by +4.97%, over three months by +14.87% and over the past year by +73.41%.
Is BTI a buy, sell or hold?
British American Tobacco has received a consensus analysts rating of 3.40.
Therefor, it is recommend to hold BTI.
- StrongBuy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the BTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60.9 | -1.9% |
| Analysts Target Price | 60.9 | -1.9% |
BTI Fundamental Data Overview February 21, 2026
Market Cap GBP = 98.13b (132.32b USD * 0.7416 USD.GBP)
P/E Trailing = 12.84
P/E Forward = 11.8064
P/S = 5.1669
P/B = 1.9765
P/EG = 0.4129
Revenue TTM = 51.48b GBP
EBIT TTM = 15.16b GBP
EBITDA TTM = 20.34b GBP
Long Term Debt = 31.33b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.36b GBP (from shortTermDebt, last quarter)
Debt = 35.07b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.24b GBP (from netDebt column, last quarter)
Enterprise Value = 129.36b GBP (98.13b + Debt 35.07b - CCE 3.84b)
Interest Coverage Ratio = 4.64 (Ebit TTM 15.16b / Interest Expense TTM 3.27b)
EV/FCF = 8.45x (Enterprise Value 129.36b / FCF TTM 15.31b)
FCF Yield = 11.83% (FCF TTM 15.31b / Enterprise Value 129.36b)
FCF Margin = 29.74% (FCF TTM 15.31b / Revenue TTM 51.48b)
Net Margin = 21.04% (Net Income TTM 10.83b / Revenue TTM 51.48b)
Gross Margin = 83.17% ((Revenue TTM 51.48b - Cost of Revenue TTM 8.66b) / Revenue TTM)
Gross Margin QoQ = 83.42% (prev 83.59%)
Tobins Q-Ratio = 1.18 (Enterprise Value 129.36b / Total Assets 109.29b)
Interest Expense / Debt = 2.18% (Interest Expense 764.0m / Debt 35.07b)
Taxrate = 25.32% (1.08b / 4.29b)
NOPAT = 11.32b (EBIT 15.16b * (1 - 25.32%))
Current Ratio = 0.87 (Total Current Assets 12.68b / Total Current Liabilities 14.52b)
Debt / Equity = 0.73 (Debt 35.07b / totalStockholderEquity, last quarter 47.93b)
Debt / EBITDA = 1.54 (Net Debt 31.24b / EBITDA 20.34b)
Debt / FCF = 2.04 (Net Debt 31.24b / FCF TTM 15.31b)
Total Stockholder Equity = 49.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.47% (Net Income 10.83b / Total Assets 109.29b)
RoE = 21.82% (Net Income TTM 10.83b / Total Stockholder Equity 49.64b)
RoCE = 18.72% (EBIT 15.16b / Capital Employed (Equity 49.64b + L.T.Debt 31.33b))
RoIC = 19.42% (NOPAT 11.32b / Invested Capital 58.27b)
WACC = 4.87% (E(98.13b)/V(133.20b) * Re(6.03%) + D(35.07b)/V(133.20b) * Rd(2.18%) * (1-Tc(0.25)))
Discount Rate = 6.03% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.84%
[DCF Debug] Terminal Value 87.45% ; FCFF base≈15.34b ; Y1≈17.31b ; Y5≈23.34b
Fair Price DCF = 302.3 (EV 687.15b - Net Debt 31.24b = Equity 655.91b / Shares 2.17b; r=5.90% [WACC]; 5y FCF grow 14.95% → 2.90% )
EPS Correlation: 10.99 | EPS CAGR: 1.74% | SUE: 0.00 | # QB: 0
Revenue Correlation: 84.76 | Revenue CAGR: 23.76% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=4.95 | Chg30d=+0.077 | Revisions Net=+1 | Growth EPS=+3.1% | Growth Revenue=+3.1%
EPS next Year (2027-12-31): EPS=5.33 | Chg30d=-0.009 | Revisions Net=+0 | Growth EPS=+7.7% | Growth Revenue=+3.2%
P/E Trailing = 12.84
P/E Forward = 11.8064
P/S = 5.1669
P/B = 1.9765
P/EG = 0.4129
Revenue TTM = 51.48b GBP
EBIT TTM = 15.16b GBP
EBITDA TTM = 20.34b GBP
Long Term Debt = 31.33b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.36b GBP (from shortTermDebt, last quarter)
Debt = 35.07b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.24b GBP (from netDebt column, last quarter)
Enterprise Value = 129.36b GBP (98.13b + Debt 35.07b - CCE 3.84b)
Interest Coverage Ratio = 4.64 (Ebit TTM 15.16b / Interest Expense TTM 3.27b)
EV/FCF = 8.45x (Enterprise Value 129.36b / FCF TTM 15.31b)
FCF Yield = 11.83% (FCF TTM 15.31b / Enterprise Value 129.36b)
FCF Margin = 29.74% (FCF TTM 15.31b / Revenue TTM 51.48b)
Net Margin = 21.04% (Net Income TTM 10.83b / Revenue TTM 51.48b)
Gross Margin = 83.17% ((Revenue TTM 51.48b - Cost of Revenue TTM 8.66b) / Revenue TTM)
Gross Margin QoQ = 83.42% (prev 83.59%)
Tobins Q-Ratio = 1.18 (Enterprise Value 129.36b / Total Assets 109.29b)
Interest Expense / Debt = 2.18% (Interest Expense 764.0m / Debt 35.07b)
Taxrate = 25.32% (1.08b / 4.29b)
NOPAT = 11.32b (EBIT 15.16b * (1 - 25.32%))
Current Ratio = 0.87 (Total Current Assets 12.68b / Total Current Liabilities 14.52b)
Debt / Equity = 0.73 (Debt 35.07b / totalStockholderEquity, last quarter 47.93b)
Debt / EBITDA = 1.54 (Net Debt 31.24b / EBITDA 20.34b)
Debt / FCF = 2.04 (Net Debt 31.24b / FCF TTM 15.31b)
Total Stockholder Equity = 49.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.47% (Net Income 10.83b / Total Assets 109.29b)
RoE = 21.82% (Net Income TTM 10.83b / Total Stockholder Equity 49.64b)
RoCE = 18.72% (EBIT 15.16b / Capital Employed (Equity 49.64b + L.T.Debt 31.33b))
RoIC = 19.42% (NOPAT 11.32b / Invested Capital 58.27b)
WACC = 4.87% (E(98.13b)/V(133.20b) * Re(6.03%) + D(35.07b)/V(133.20b) * Rd(2.18%) * (1-Tc(0.25)))
Discount Rate = 6.03% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.84%
[DCF Debug] Terminal Value 87.45% ; FCFF base≈15.34b ; Y1≈17.31b ; Y5≈23.34b
Fair Price DCF = 302.3 (EV 687.15b - Net Debt 31.24b = Equity 655.91b / Shares 2.17b; r=5.90% [WACC]; 5y FCF grow 14.95% → 2.90% )
EPS Correlation: 10.99 | EPS CAGR: 1.74% | SUE: 0.00 | # QB: 0
Revenue Correlation: 84.76 | Revenue CAGR: 23.76% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=4.95 | Chg30d=+0.077 | Revisions Net=+1 | Growth EPS=+3.1% | Growth Revenue=+3.1%
EPS next Year (2027-12-31): EPS=5.33 | Chg30d=-0.009 | Revisions Net=+0 | Growth EPS=+7.7% | Growth Revenue=+3.2%